ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis

Study limitation reported by the research below: “Three distinct semaglutide formulations and doses were pooled (SC 1.0 mg, SC 2.4 mg, oral 14 mg); effects may not be uniform across all routes and doses.”

Papers